Wasatch Advisors Inc Exagen Inc. Transaction History

Wasatch Advisors Inc

$18.5 Billion
Q2 2024

A detailed history of Wasatch Advisors Inc transactions in Exagen Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 762,259 shares of XGN stock, worth $2.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

762,259

Previous 786,895 3.13%

Holding current value

$2.39 Million

Previous $1.25 Million 10.87%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.36 - $2.05 $33,504 - $50,503	-24,636 Reduced 3.13%	762,259 $1.39 Million
Q1 2024 Apr 18, 2024	SELL	$1.42 - $2.3 $90,046 - $145,849	-63,413 Reduced 7.46%	786,895 $1.25 Million
Q4 2023 Feb 14, 2024	SELL	$1.45 - $2.39 $8,649 - $14,256	-5,965 Reduced 0.7%	850,308 $1.69 Million
Q3 2023 Nov 14, 2023	SELL	$2.24 - $2.93 $323,839 - $423,593	-144,571 Reduced 14.44%	856,273 $2.07 Million
Q2 2023 Aug 07, 2023	BUY	$2.36 - $3.48 $667 - $984	283 Added 0.03%	1,000,844 $2.9 Million
Q4 2022 Feb 14, 2023	SELL	$2.1 - $3.4 $21,611 - $34,989	-10,291 Reduced 1.02%	1,000,561 $2.4 Million
Q3 2022 Nov 14, 2022	SELL	$2.69 - $8.68 $2,940 - $9,487	-1,093 Reduced 0.11%	1,010,852 $2.74 Million
Q2 2022 Aug 12, 2022	SELL	$4.18 - $7.74 $323,394 - $598,820	-77,367 Reduced 7.1%	1,011,945 $5.81 Million
Q1 2022 May 13, 2022	SELL	$7.12 - $11.06 $117,109 - $181,914	-16,448 Reduced 1.49%	1,089,312 $8.75 Million
Q4 2021 Feb 15, 2022	BUY	$8.97 - $14.08 $67,292 - $105,628	7,502 Added 0.68%	1,105,760 $12.9 Million
Q3 2021 Nov 12, 2021	SELL	$10.25 - $15.21 $6.1 Million - $9.06 Million	-595,420 Reduced 35.16%	1,098,258 $14.9 Million
Q2 2021 Aug 12, 2021	BUY	$12.4 - $17.92 $26,920 - $38,904	2,171 Added 0.13%	1,693,678 $25.4 Million
Q1 2021 May 10, 2021	BUY	$13.9 - $22.0 $8.99 Million - $14.2 Million	647,104 Added 61.96%	1,691,507 $29.6 Million
Q4 2020 Feb 12, 2021	BUY	$11.19 - $16.05 $1.13 Million - $1.61 Million	100,572 Added 10.66%	1,044,403 $13.8 Million
Q3 2020 Nov 10, 2020	BUY	$10.56 - $16.69 $3.44 Million - $5.44 Million	325,786 Added 52.71%	943,831 $10.2 Million
Q2 2020 Aug 12, 2020	SELL	$11.0 - $16.7 $818,114 - $1.24 Million	-74,374 Reduced 10.74%	618,045 $7.67 Million
Q1 2020 May 08, 2020	BUY	$12.7 - $25.95 $4.33 Million - $8.85 Million	341,006 Added 97.04%	692,419 $11 Million
Q4 2019 Feb 13, 2020	SELL	$12.61 - $28.48 $244,823 - $552,939	-19,415 Reduced 5.24%	351,413 $8.93 Million
Q3 2019 Nov 14, 2019	BUY	$14.5 - $17.5 $5.38 Million - $6.49 Million	370,828 New	370,828 $5.74 Million

Others Institutions Holding XGN

# of Institutions

Shares Held

6.29M

Call Options Held

2.5K

Put Options Held

200

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $51.1M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Account

Wasatch Advisors Inc Exagen Inc. Transaction History